Afify Alaa, Huang Eric C, Jeong Matthew, Urayama Shiro
Division of Cytopathology, Department of Pathology and Laboratory Medicine, University of California, Davis, Sacramento, California, 95817.
Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of California, Davis, California.
Diagn Cytopathol. 2016 Jan;44(1):32-8. doi: 10.1002/dc.23383. Epub 2015 Oct 15.
Evaluation of pancreatic mass is routinely performed by endoscopic ultrasound-guided fine needle aspiration (EUS-FNA). However, molecular analyses of the tumor cells on FNA samples are limited by the significant cellular heterogeneity. The goal of the current study is to evaluate a magnetic immunoconcentration technique in isolating pancreatic epithelial cells from needle aspirates, and to demonstrate that the isolated cells could be utilized for molecular analysis.
Pancreatic EUS-FNA specimens were processed and stored at -80°C. Based on the cytopathological diagnosis, 17 adenocarcinoma, 3 lymphoproliferative, and 3 benign cases were retrieved from the collection for further analyses. Epithelial cells were isolated using antihuman epithelial cell specific antibody-bound magnetic beads, and the isolated cellular component was confirmed cytologically. Genomic DNA was extracted, quantitated, and evaluated with methylation-specific PCR for cyclin D2 in 8 adenocarcinoma cases.
After optimization, malignant epithelial cells were successfully isolated from all adenocarcinoma cases. Normal pancreatic ductal cells were isolated from three benign cases. No cells were retrieved after immunomagnetic isolation in all three lymphoproliferative cases. DNA yields were 5-2646 ng, with a mean of 357 ng. Methylation-specific PCR for cyclin D2 on the 8 carcinoma cases showed methylated state at the promoter region, demonstrating feasible evaluation of the methylation status.
The magnetic immunoconcentration of pancreatic EUS-FNA specimen described here is a practical method of isolating pancreatic epithelial cells from needle aspirates. Isolated cells were sufficient for performing subsequent molecular analysis.
胰腺肿块的评估通常通过内镜超声引导下细针穿刺抽吸术(EUS-FNA)进行。然而,FNA样本中肿瘤细胞的分子分析受到显著细胞异质性的限制。本研究的目的是评估一种磁性免疫浓缩技术,用于从针吸物中分离胰腺上皮细胞,并证明分离出的细胞可用于分子分析。
胰腺EUS-FNA标本经过处理后保存在-80°C。根据细胞病理学诊断,从收集的标本中选取17例腺癌、3例淋巴增殖性疾病和3例良性病例进行进一步分析。使用抗人上皮细胞特异性抗体结合的磁珠分离上皮细胞,并通过细胞学方法确认分离出的细胞成分。提取8例腺癌病例的基因组DNA,进行定量,并采用甲基化特异性PCR检测细胞周期蛋白D2。
经过优化,成功从所有腺癌病例中分离出恶性上皮细胞。从3例良性病例中分离出正常胰腺导管细胞。在所有3例淋巴增殖性疾病病例中,免疫磁珠分离后均未获得细胞。DNA产量为5-2646 ng,平均为357 ng。对8例癌病例进行的细胞周期蛋白D2甲基化特异性PCR显示启动子区域呈甲基化状态,表明甲基化状态的评估可行。
本文所述的胰腺EUS-FNA标本磁性免疫浓缩是一种从针吸物中分离胰腺上皮细胞的实用方法。分离出的细胞足以进行后续分子分析。